Comprehensive evaluation of the contribution of X chromosome genes to platinum sensitivity.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3079551)

Published in Mol Cancer Ther on January 20, 2011

Authors

Eric R Gamazon1, Hae Kyung Im, Peter H O'Donnell, Dana Ziliak, Amy L Stark, Nancy J Cox, M Eileen Dolan, Rong Stephanie Huang

Author Affiliations

1: Section of Genetic Medicine, Department of Medicine, The University of Chicago, 900 E. 57 street, KCBD room 7148, Chicago, IL 60637, USA.

Articles cited by this

A haplotype map of the human genome. Nature (2005) 105.70

Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 88.64

Population genomics of human gene expression. Nat Genet (2007) 24.49

Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet (2007) 9.04

SCAN: SNP and copy number annotation. Bioinformatics (2009) 5.96

'Omic' and hypothesis-driven research in the molecular pharmacology of cancer. Curr Opin Pharmacol (2002) 4.54

Evaluation of genetic variation contributing to differences in gene expression between populations. Am J Hum Genet (2008) 4.01

Gene-expression variation within and among human populations. Am J Hum Genet (2007) 3.84

Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. Am J Hum Genet (2007) 3.05

Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci. Proc Natl Acad Sci U S A (2010) 2.43

DNA microarrays in clinical oncology. J Clin Oncol (2002) 2.40

Effect of population and gender on chemotherapeutic agent-induced cytotoxicity. Mol Cancer Ther (2007) 2.05

Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines. Pharmacogenomics J (2010) 1.66

Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients. Ann Oncol (2003) 1.38

Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB. Eur J Pharmacol (2010) 1.14

Cloning and characterization of NE-dlg: a novel human homolog of the Drosophila discs large (dlg) tumor suppressor protein interacts with the APC protein. Oncogene (1997) 1.13

Population differences in platinum toxicity as a means to identify novel genetic susceptibility variants. Pharmacogenet Genomics (2010) 0.97

Gender in the pharmacy: does it matter? Science (2005) 0.93

Identification of a cDNA encoding an isoform of human CTP synthetase. Biochim Biophys Acta (2000) 0.88

X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells. Clin Invest Med (2003) 0.86

DLG3, the gene encoding human neuroendocrine Dlg (NE-Dlg), is located within the 1.8-Mb dystonia-parkinsonism region at Xq13.1. Genomics (1998) 0.80

Articles by these authors

Finding the missing heritability of complex diseases. Nature (2009) 67.95

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61

Influenza-associated hospitalizations in the United States. JAMA (2004) 18.23

Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science (2005) 17.19

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med (2009) 15.02

Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med (2005) 14.59

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol (2009) 12.13

Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet (2010) 10.75

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep (2010) 10.59

The allelic architecture of human disease genes: common disease-common variant...or not? Hum Mol Genet (2002) 10.08

The global circulation of seasonal influenza A (H3N2) viruses. Science (2008) 10.05

Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science (2009) 8.61

A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science (2007) 8.38

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA (2006) 8.06

Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol (2005) 7.88

Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med (2005) 6.83

Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc Natl Acad Sci U S A (2006) 6.35

A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A (2012) 6.27

Transmission of equine influenza virus to dogs. Science (2005) 6.11

SCAN: SNP and copy number annotation. Bioinformatics (2009) 5.96

Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. J Infect Dis (2002) 5.92

Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep (2009) 5.80

Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet (2005) 5.70

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep (2007) 5.32

Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis (2007) 5.21

Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2006) 5.19

Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev (2006) 5.08

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2004) 5.00

Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nat Genet (2011) 4.93

Implementing genomic medicine in the clinic: the future is here. Genet Med (2013) 4.89

A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Proc Natl Acad Sci U S A (2007) 4.35

Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet (2011) 4.26

Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet (2005) 4.15

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13

Evaluation of genetic variation contributing to differences in gene expression between populations. Am J Hum Genet (2008) 4.01

Global concerns regarding novel influenza A (H7N9) virus infections. N Engl J Med (2013) 3.88

Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci U S A (2007) 3.77

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2005) 3.50

Genetic architecture of transcript-level variation in humans. Am J Hum Genet (2008) 3.36

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2002) 3.27

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study. Lancet (2013) 3.21

In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. Virology (2011) 3.19

Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. Am J Hum Genet (2007) 3.05

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2003) 2.96

Identification of type 2 diabetes genes in Mexican Americans through genome-wide association studies. Diabetes (2007) 2.91

Mouse models of human AML accurately predict chemotherapy response. Genes Dev (2009) 2.75

Serologic evidence of H1 swine Influenza virus infection in swine farm residents and employees. Emerg Infect Dis (2002) 2.75

Identification, replication, and functional fine-mapping of expression quantitative trait loci in primary human liver tissue. PLoS Genet (2011) 2.68

Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine (2008) 2.56

Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001. J Virol (2005) 2.51

Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. J Clin Oncol (2009) 2.47

Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957-1972: evidence for genetic divergence and multiple reassortment events. Virology (2004) 2.44

Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci. Proc Natl Acad Sci U S A (2010) 2.43

Genetic compatibility and virulence of reassortants derived from contemporary avian H5N1 and human H3N2 influenza A viruses. PLoS Pathog (2008) 2.38

Reassortment between avian H5N1 and human H3N2 influenza viruses in ferrets: a public health risk assessment. J Virol (2009) 2.33

A nondegenerate code of deleterious variants in Mendelian loci contributes to complex disease risk. Cell (2013) 2.28

Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. Virology (2011) 2.28

Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med (2008) 2.24

Pause on avian flu transmission research. Science (2012) 2.24

Effect of population and gender on chemotherapeutic agent-induced cytotoxicity. Mol Cancer Ther (2007) 2.05

Family clustering of avian influenza A (H5N1). Emerg Infect Dis (2005) 2.04

Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet (2004) 2.03

The neutrophil alloantigen HNA-3a (5b) is located on choline transporter-like protein 2 and appears to be encoded by an R>Q154 amino acid substitution. Blood (2009) 2.02

Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry (2006) 2.02

A statistical method for identification of polymorphisms that explain a linkage result. Am J Hum Genet (2002) 1.99

Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep (2014) 1.97

Pharmacogenomic discovery using cell-based models. Pharmacol Rev (2009) 1.96

Identification of common genetic variants that account for transcript isoform variation between human populations. Hum Genet (2008) 1.96

Evolution of highly pathogenic H5N1 avian influenza viruses in Vietnam between 2001 and 2007. PLoS One (2008) 1.91

Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Am J Hum Genet (2006) 1.89

Accounting for animal movement in estimation of resource selection functions: sampling and data analysis. Ecology (2009) 1.86

Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets. Proc Natl Acad Sci U S A (2012) 1.80

Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice. Virus Res (2007) 1.77

Experimental evaluation of the FluChip diagnostic microarray for influenza virus surveillance. J Clin Microbiol (2006) 1.76

Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst (2010) 1.76

Mapping genes that contribute to daunorubicin-induced cytotoxicity. Cancer Res (2007) 1.73

The HapMap Resource is Providing New Insights into Ourselves and its Application to Pharmacogenomics. Bioinform Biol Insights (2008) 1.73

Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68

Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans. Mol Cancer Ther (2008) 1.67

Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis (2011) 1.66

Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses. Vaccine (2006) 1.66

A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucose. Diabetes (2009) 1.65

Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trials. Eur Urol (2012) 1.64

Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma. J Clin Oncol (2005) 1.63

Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation. Pharmacogenomics (2012) 1.63

Seasonal influenza vaccines. Curr Top Microbiol Immunol (2009) 1.63

A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter. Cancer Res (2005) 1.62

Geographic and haplotype structure of candidate type 2 diabetes susceptibility variants at the calpain-10 locus. Am J Hum Genet (2002) 1.61

Somatic acquisition and signaling of TGFBR1*6A in cancer. JAMA (2005) 1.59

Coverage and characteristics of the Affymetrix GeneChip Human Mapping 100K SNP set. PLoS Genet (2006) 1.58

GEL: a novel genotype calling algorithm using empirical likelihood. Bioinformatics (2006) 1.58

MChip: a tool for influenza surveillance. Anal Chem (2006) 1.57